TrialAnnals of hematology2026

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib.

Lucía Pérez-Lamas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.